1551
251
145
193
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T17695 | Br-PEG7-Br | Others , PROTAC Linker | |
Br-PEG7-Br is a PEG-based PROTAC linker that can be used in PROTAC synthesis. | |||
T18153 | M-PEG16-Br | Others , PROTAC Linker | |
m-PEG16-Br is a PEG-based PROTAC linker. m-PEG16-Br can be used in the synthesis of PROTACs. | |||
T18064 | Lenalidomide-Br | Ligand for E3 Ligase | |
Lenalidomide-Br (Compound 41) is a derivative of Lenalidomide, which serves as a ligand for cereblon (CRBN) - an E3 ubiquitin ligase involved in protein recruitment. This compound, Lenalidomide-Br, can be conjugated to a... | |||
T18215 | M-PEG7-Br | Others , PROTAC Linker | |
m-PEG7-Br is a PEG-based PROTAC linker. m-PEG7-Br can be used in the synthesis of PROTACs. | |||
T18125 | M-PEG11-Br | Others , PROTAC Linker | |
m-PEG11-Br is a PEG-based PROTAC linker. m-PEG11-Br can be used in the synthesis of PROTACs. | |||
T18161 | M-PEG2-Br | Others , PROTAC Linker | |
m-PEG2-Br is a PEG-based PROTAC linker. m-PEG2-Br can be used in the synthesis of PROTACs. | |||
T17694 | Br-C10-methyl ester | Others , PROTAC Linker | |
Br-C10-methyl ester, a PROTAC linker characterized by its alkyl/ether composition, plays a crucial role in the synthesis of a series of PROTACs (MS432). This compound incorporates a dual-ligand system connected via a lin... | |||
T17654 | Boc-NH-C6-Br | Others | |
Boc-NH-C6-Br is a cleavable linker used for antibody-drug conjugates (ADC)[1]. | |||
T22136 | PRL-3 Inhibitor I | PRL-3 Inhibitor,BR-1 | Phosphatase , Others |
PRL-3 Inhibitor I (BR-1) is a phosphatase of regenerating liver 3 (PRL-3) inhibitor which blocks the migration and invasion of metastatic cancer cells. | |||
TP1549L | NY-BR-1 p904 A2 acetate(347142-73-8 free base) | Others | |
T-cell clones specific for this NY-BR-1 p904 A2 acetate(347142-73-8 free base) can recognize breast tumor cells expressing NY-BR-1. | |||
T38717 | Cyclohexane-PEG1-Br | Cyclohexane-PEG1-Br | |
Cyclohexane-PEG1-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome syst... | |||
T38689 | Propargyl-PEG5-Br | Propargyl-PEG5-Br | |
Propargyl-PEG5-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system... | |||
T39228 | Br-PEG4-THP | Br-PEG4-THP | |
Br-PEG4-THP is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system withi... | |||
T39398 | Propargyl-PEG6-Br | Propargyl-PEG6-Br | |
Propargyl-PEG6-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system... | |||
T38647 | M-PEG9-Br | m-PEG9-Br | |
m-PEG9-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within ... | |||
T40389 | Br-PEG3-ethyl acetate | Br-PEG3-ethyl acetate | |
Br-PEG3-ethyl acetate is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome sy... | |||
T40390 | Br-PEG6-C2-acid | Br-PEG6-C2-acid | |
Br-PEG6-C2-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system w... | |||
T39131 | Boc-NH-C4-Br | Boc-NH-C4-Br | |
Boc-NH-C4-Br is a alkyl chain-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome sys... | |||
T40574 | Br-C3-methyl ester | Br-C3-methyl ester | |
Br-C3-methyl ester is an alkyl/ether-based PROTAC linker utilized for the synthesis of PROTAC PD-1/PD-L1 degrader-1. | |||
T39021 | N-Ethylpropionamide-PEG1-Br | N-Ethylpropionamide-PEG1-Br | |
N-Ethylpropionamide-PEG1-Br is a polyethylene glycol (PEG) derived PROTAC linker utilized for the synthesis of Proteolysis Targeting Chimeras (PROTACs). | |||
T38505 | Br-Boc-C2-azido | Br-Boc-C2-azido | |
Br-Boc-C2-azido is a alkyl/ether-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome ... | |||
T39857 | 8-Br-GTP | 8-Bromoguanosine-5'-triphosphate,8-Br-GTP | |
8-Br-GTP, an analog of GTP, functions as both a competitive inhibitor of FtsZ polymerization and GTPase activity (with a K i value of 31.8 μM). Moreover, it is capable of facilitating nucleic acid modification. | |||
T27312 | Fentiazac | Donorest,Flogene,BR-700 | Others |
Fentiazac(BR-700) is an orally active nonsteroidal alkanoic acid derivative with significant analgesic, anti-inflammatory, and antipyretic activity.Fentiazac is used in the study of inflammatory diseases such as rheumato... | |||
T2322 | Fimasartan | BR-A-657,Kanarb | Apoptosis , RAAS |
Fimasartan (BR-A-657) is a non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and heart failure. Concurrent administration of fimasartan with diuretic hydrochlorothiazide has show... | |||
T13981 | β-Naphthoflavone-CH2-Br | β-NF-CH2-Br | Others |
β-Naphthoflavone-CH2-Br is an arylhydrocarbon receptor (AhR) ligand. β-Naphthoflavone-CH2-Br used to synthesize the PROTAC β-NF-JQ1. | |||
T1179 | Tiotropium bromide | Tiopropium,BA679 BR | AChR |
Tiotropium bromide (BA679 BR) is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium is a muscarinic receptor antagonist, on topical a... | |||
T39160 | N-Ethyl-N-methylpropionamide-PEG1-Br | N-Ethyl-N-methylpropionamide-PEG1-Br | |
N-Ethyl-N-methylpropionamide-PEG1-Br is a PEG-derived PROTAC linker suitable for the synthesis of PROTACs. | |||
T39967 | Br-DAPI | ||
Br-DAPI is a water-soluble, cell-permeable, DNA-binding photosensitizer. | |||
T39286 | Br-PBTC | ||
Br-PBTC is a highly potent, 2/4 subtype-selective positive allosteric modulator of nicotinic acetylcholine receptors (nAChRs). It specifically targets α2β2, α2β4, α4β2, α4β4, (α4β2)2α4, and (α4β2)2β2 subtypes of nAChRs, ... | |||
TP1549 | NY-BR-1 p904 (A2) | NY-BR-1 p904 A2 | |
T-cell clones specific for this NY-BR-1 epitope (p904) can recognize breast tumor cells expressing NY-BR-1. | |||
T6522 | Guanabenz Acetate | Wy8678 acetate,BR-750,Wytensin | Adrenergic Receptor |
Guanabenz Acetate (Wytensin) is a specific agonist of adrenergic receptor. The pEC50 for α2a-adrenergic receptor, α2b-adrenergic receptor and α2c-adrenergic receptor is 8.25, 7.01 and ~5, respectively. | |||
T10108 | 3-Bromocytisine | (-)-3-Bromocytisine,(-)-9-Bromocytisine,3-Br-cytisine | AChR |
3-Bromocytisine ((-)-3-Bromocytisine) is an effective agonist of nAChR (IC50s: 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7). | |||
T38409 | Lenalidomide-5-Br | ||
Lenalidomide-5-Br is a Lenalidomide derivative that functions as a ligand for cereblon (CRBN), thereby facilitating the recruitment of CRBN protein. It can be conjugated to the protein ligand through a linker to generate... | |||
T6707 | Tiotropium Bromide hydrate | BA-679 BR hydrate,BA 679BR | AChR |
Tiotropium Bromide hydrate (BA-679 BR hydrate) is a potent anticholinergic and bronchodilator, serving as a muscarinic receptor antagonist, specifically targeting mAChR. It is developed for treating chronic obstructive a... | |||
T60122 | Aldometanib | Compound IA-47 (Br- base 2246625-81-8) | Others , AMPK |
Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK. Aldometanib can be used for the research of metabolic h... | |||
T16619 | Propargyl-PEG4-Br | Others | |
Propargyl-PEG4-Br is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T14770 | Br-PEG3-OH | Others | |
Br-PEG3-OH is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T15929 | M-PEG8-Br | Others | |
m-PEG8-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within ... | |||
T14769 | Br-PEG3-CH2COOH | Others | |
Br-PEG3-CH2COOH is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system w... | |||
T18119 | M-PEG10-Br | Others | |
m-PEG10-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T14773 | Br-PEG4-OH | Others | |
Br-PEG4-OH is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T18168 | M-PEG24-Br | Others | |
m-PEG24-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T15909 | M-PEG6-Br | Others | |
m-PEG6-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within ... | |||
T15891 | M-PEG5-Br | Others | |
m-PEG5-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within ... | |||
T15872 | M-PEG4-Br | Others | |
m-PEG4-Br is a cleavable ADC linker used in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab. m-PEG4-Br is placed distally from the monomethyl auristatin E (MMAE) payload to yield an ADC with altered hydrop... | |||
T18204 | M-PEG48-Br | Others | |
m-PEG48-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T18135 | M-PEG12-Br | Others | |
m-PEG12-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T18193 | M-PEG36-Br | Others | |
m-PEG36-Br is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within... | |||
T30655 | Naphthol AS-BR | C.I. 37575 | |
C.I. 37575 is a dye. | |||
T14771 | Br-PEG4-C2-Boc | Others | |
Br-PEG4-C2-Boc is a cleavable 4-unit PEG ADC linker employed for the synthesis of antibody-drug conjugates (ADCs)[1]. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T18927 | Br-Mmc | 4-Bromomethyl-7-methoxycoumarin | Others |
Br-Mmc (4-Bromomethyl-7-methoxycoumarin) is used as a new fluorescence label for fatty acids. It is used for the determination of fatty acids by HPLC or TLC. | |||
TN3535 | BR-Xanthone A | Others | |
BR-Xanthone A is a natural product for research related to life sciences. The catalog number is TN3535 and the CAS number is 112649-48-6. | |||
T7132 | (Rac)-Brassinazole | BRASSINAZOLE | P450 |
(Rac)-Brassinazole are a class of phytohormones with essential roles in plant growth and development, including the promotion of stem elongation and cell division. Brassinazole is a triazole-type brassinosteroid biosynth... | |||
T5514 | Epibrassinolide | 24-Epibrassinolide,B1105,BP55 | Apoptosis |
Epibrassinolide (BP55) (EBR) is a biologically active compound of the brassinosteroids, is a natural brassinosteroid (BR) derivative, is a plant regulator with a similar structure to mammalian steroids. | |||
TN3543 | Bruceoside A | Others | |
Bruceoside A is a bitter wood glycoside that can be isolated from opuntia and has anticancer and tumor activity and can be used with the study of leukemia. | |||
T3O2709 | Bronze Red | Scarlet 808 | Others |
Bronze Red, an amide class organic compound, is utilized for content determination, identification, and pharmacological experiments. | |||
T1255 | Tobramycin | NSC 180514,Nebramycin Factor 6,Deoxykanamycin B | ribosome , Antibacterial , Antibiotic |
Tobramycin (NSC-180514) is an aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. | |||
TN7165 | 3,6-Dibromocarbazole | 3,6-Dibromo-9H-carbazole | Others |
3,6-Dibromocarbazole (3,6-Dibromo-9H-carbazole) is a marine derived natural products found in Kyrtuthrix maculans. | |||
TN7180 | 2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- | Meridianin C | Others |
2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- (Meridianin C) is a marine derived natural products found in Aplidium meridianum. | |||
TN7186 | 1H-Indole-3-Carboxylic Acid,6-Bromo-,Methyl Ester | Methyl 6-bromo-1H-indole-3-carboxylate | Others |
1H-Indole-3-Carboxylic Acid,6-Bromo-,Methyl Ester (Methyl 6-bromo-1H-indole-3-carboxylate) is a marine derived natural products found in Smenospongia sp. | |||
T7913 | 2-Bromobiphenyl | Others | |
2-Bromobiphenyl is a persistent organic pollutant (POP) found primarily in soil and water. It is a known human carcinogen and has been linked to a variety of health effects including reproductive and developmental toxici... | |||
TN7155 | Methyl 3-bromo-4,5-dihydroxybenzoate | Methyl 3,4-dihydroxy-5-bromobenzoate,3-bromo-4,5-dihydroxybenzoic acid methyl ester | Others |
Methyl 3-bromo-4,5-dihydroxybenzoate (3-bromo-4,5-dihydroxybenzoic acid methyl ester) is a marine derived natural products found in Rhodomela confervoides. | |||
TN7167 | 2,4,5-Tribromoimidazole | 2,4,5-Tribromo-1H-imidazole | Others |
2,4,5-Tribromoimidazole (2,4,5-Tribromo-1H-imidazole) is a marine derived natural products found in Hexaplex trunculus. | |||
TN7205 | Methyl 5,6-dibromo-1H-indole-3-carboxylate | 5,6-Dibromo-1H-indole-3-carboxylic acid methyl ester | Others |
Methyl 5,6-dibromo-1H-indole-3-carboxylate (5,6-Dibromo-1H-indole-3-carboxylic acid methyl ester) is a marine derived natural products found in Smenospongia sp. | |||
TN7249 | Nor-rubrofusarin gentiobioside | ||
Nor-rubrofusarin gentiobioside is a natural product found in the leguminous plant Cassia vulgaris. | |||
TN7146 | 2,6-Dibromo-4-(hydroxymethyl)phenol | ZINC2525484,3,5-dibromo-p-hydroxybenzyl alcohol,3,5-Dibromo-4-Hydroxybenzyl alcohol | Others |
2,6-Dibromo-4-(hydroxymethyl)phenol (3,5-dibromo-p-hydroxybenzyl alcohol) is a marine derived natural products found in Thelepus setosus. | |||
TN7197 | 6-Chloro-2,4-dibromophenol | 2,4-dibromo-6-chloro-phenol,2,4-dibromo-6-chlorophenol,ZINC397569 | Others |
6-Chloro-2,4-dibromophenol (2,4-dibromo-6-chlorophenol) is a marine derived natural products found in Pseudoalteromonas luteoviolacea. | |||
TN7207 | Ethyl6-bromo-1H-indole-3-carboxylate | Ethyl 6-Bromoindole-3-carboxylate,ethyl 6-bromo-3-indolecarboxylate,ZINC13379655 | Others |
Ethyl6-bromo-1H-indole-3-carboxylate (Ethyl 6-Bromoindole-3-carboxylate) is a marine derived natural products found in Pleroma menoui. | |||
T0086 | Galanthamine hydrobromide | Galantamine hydrobromide,Galanthamine HBr | AChR , AChE |
Galanthamine hydrobromide (Galantamine hydrobromide), a long-acting and centrally active AChE inhibitor (IC50:410 nM), is an allosteric potentiator at neuronal nicotinic ACh receptors. | |||
TQ0118 | Britannilactone | Desacetylinulicin | Others |
Britannilactone (Desacetylinulicin) is a sesquiterpene from Inula britannica with anti-inflammatory and anti-tumor activity.Britannilactone has been associated with this antimelanotic activity and can be used in studies ... | |||
T2S1682 | Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside | Pinocembrin 7-O-(3''-galloyl-4'',6''-(S)-hexahydroxydiphenoyl)-beta-D-glucose,pinocembrin-7-o-3-o-galloyl-4-6-hexahydroxydiphenoyl-beta-d-glucoside | Amylase |
Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside can moderately inhibit α-amylase activity, with the IC50 value of 0.03 umol/ml. | |||
T5718 | L-(+)-Abrine | L-N-Methyltryptophan,N-α-Methyl-L-tryptophan,L-ABRINE | Others |
L-(+)-Abrine (L-N-Methyltryptophan) is a toxic protein found in the jequirity seed.,can be used as a biomarker for abrin exposure. | |||
T7924 | 8-Bromoguanosine | Others | |
8-Bromoguanosine is a brominated derivative of guanosine. It is activate lymphocytes through an intracellular mechanism to exert immunostimulatory effects. | |||
TN1799 | Isorubrofusarin-6-O-β-gentiobioside | Isorubrofusarin 10-gentiobioside | BACE , AChR |
Isorubrofusarin-6-O-β-gentiobioside is derived from from Cassia obtusifolia Linn seeds and shows promising inhibitory activity against AChE and BACE1. | |||
TN1012L | Febrifugine dihydrochloride | ISF-2123,Propyldazine hydrochloride,Atensil,(+)-Febrifugine dihydrochloride,Pildralazine dihydrochloride | Parasite |
Febrifugine dihydrochloride (Propyldazine hydrochloride) is a biochemical with therapeutic activity regarding malaria, cancer, fibrosis and inflammatory diseases. | |||
T3403 | Glabridin | Q-100692,KB-289522,LS-176045 | Reactive Oxygen Species , Tyrosinase , GABA Receptor , Antibacterial , PPAR |
Glabridin (KB-289522) may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels; may possess a therapeutic effect on... | |||
T3151 | Brassinolide | Brassin lactone,24-Epibrassinolide | Apoptosis , Others |
Brassinolide (Brassin lactone) is a plant hormone isolated from rapeseed (Brassica napus) promoting stem elongation and cell division. | |||
TQ0211 | Brusatol | (+)-Brusatol,NSC 172924 | Others , Ferroptosis , Nrf2 |
Brusatol (NSC-172924) is a natural product isolated from the Brucea javanica plant. It inhibits Nrf2. | |||
T4672 | Brevilin A | Apoptosis , Anti-infection , JAK , STAT , Autophagy | |
Brevilin A is a sesquiterpene lactone isolated from Centipeda minima, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells with anti-tumor activity. Brevilin A is a selective inhibitor of JAK-STAT si... | |||
T5793 | Britannin | Apoptosis , AMPK , Autophagy | |
Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells. | |||
T4962 | Zingibroside R1 | Ginsenoside Z-R1 | HIV Protease |
Zingibroside R1 (Ginsenoside Z-R1) has anti-HIV-1 activity. | |||
T6062 | Brefeldin A | BFA,Ascotoxin,Cyanein,Decumbin | ATPase , Mitophagy , Antibiotic , Autophagy , HSV , CRISPR/Cas9 |
Brefeldin A (Cyanein) belongs to the class of macrolide antibiotics and is an ATPase inhibitor (IC50=0.2 μM). Brefeldin A can induce tumor cell differentiation and apoptosis, and also possesses autophagy inhibitory activ... | |||
T0625 | Theobromine | 3, 7-Dimethylxanthine,3,7-Dimethylxanthine | Endogenous Metabolite , PDE , Adenosine Receptor |
Theobromine (3,7-Dimethylxanthine), a xanthine alkaloid, is used as a bronchodilator and as a vasodilator. | |||
TN7223 | 3,5-Dibromo-4-methoxybenzoic acid | Others | |
3,5-Dibromo-4-methoxybenzoic acid was isolated from the Malagasy sponge Amphimedon sp. | |||
TN7191 | 4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine | 5-bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine,5-bromo-7H-pyrrolo[2,3-d]pyrimidin-4-amine | Others |
4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine (5-bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine) is a marine derived natural products found in Echinodictyum sp. | |||
T3208 | Brevianamide F | Cyclo-L-tryptophyl-L-proline,cyclo-(L-Trp-L-Pro),Cyclo(L-Pro-L-Trp) | BCRP , PI3K , Antibacterial |
Brevianamide F (Cyclo(L-Pro-L-Trp)), also known as cyclo-(L-Trp-L-Pro), belongs to a class of naturally occurring 2,5-diketopiperazines. Brevianamide F possess interesting breast cancer resistance protein inhibitory acti... | |||
TN7163 | Methyl 4-bromopyrrole-2-carboxylate | 4-Bromo-2-(methoxycarbonyl)-1H-pyrrole,methyl 4-bromo-1H-pyrrole-2-carboxylate | Others |
Methyl 4-bromopyrrole-2-carboxylate (4-Bromo-2-(methoxycarbonyl)-1H-pyrrole) is a marine derived natural products found in Lissodendoryx sp. | |||
TN1691 | Glabrol | P450 , NF-κB , NO Synthase , Acyltransferase | |
Glabrol is a PTP1B inhibitor, it is also a CYP1B1 inhibitor, it shows inhibition of CYP1B1 in live cell assay with the IC50 value of 15uM. | |||
TN1114 | Carabrone | Antibacterial , Antifection | |
Carabrone, a botanical bicyclic sesquiterpenic lactone, is a promising fungicidal agent that can effectively control G. tritici. | |||
TN2165 | Rubrofusarin gentiobioside | Rubrofusarin-6-O-beta-D-gentiobioside | ERK , NF-κB , TGF-beta/Smad |
Rubrofusarin gentiobioside (Rubrofusarin-6-O-beta-D-gentiobioside) can significantly decrease the expression of TGF-beta1 and fibronectin and NF-kappaB DNA binding activity, suggests that it has potential as a preventive... | |||
T7479 | Ambroxide | (-)-Ambroxide | Others |
Ambroxide ((-)-Ambroxide) is a naturally product,is one of the key constituents of ambergris. | |||
T18930 | Bromothymol Blue | Others | |
Bromothymol Blue is a pH indicator. It is yellow when it is acidic and blue when it is alkaline. | |||
T2S2046 | Bruceine A | Dihydrobrusatol,NSC31616 | Antibiotic , Parasite |
Bruceine A (NSC-31616)(NSC-310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. | |||
TN1451 | Brevifolincarboxylic acid | AhR , Aryl Hydrocarbon Receptor , Glucosidase | |
Brevifolincarboxylic acid is a natural product isolated from Polygonum capitatum, it has inhibitory effect on the aryl hydrocarbon receptor (AhR). Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 3... | |||
TN2078 | Pinocembrin chalcone | 2',4',6'-Trihydroxychalcone,Pinocembrinchalcone | Calcium Channel , Tyrosinase , Antibacterial , Antifection |
Pinocembrin chalcone is an inhibitor of tyrosinase with antimutagenic effects. Pinocembrin chalcone can be used in studies about the prevention of gastric ulcers. | |||
T4373 | Brassinin | BSN | Antifungal |
Brassinin (BSN) (BSN) is a phytoalexin isolated from B. campestris that exhibits anticancer, chemopreventative, antiproliferative, and antifungal activities. | |||
T13693 | Fibrin | Others | |
Fibrin, the primary constituent of blood clots, is an insoluble protein essential for coagulation. Isolated from bovine blood, this protein is notably synthesized in response to bleeding. | |||
T6560 | Lappaconitine hydrobromide | Lappaconite HBr,Allapinine | Others |
Lappaconitine hydrobromide (Allapinine) is a kind of alkaloid extracted from Aconitum sinomontanum Nakai. It has anti-inflammatory effects. | |||
TN7140 | 1H-Pyrrole-2-carboxylic acid, 4,5-dibromo-1-methyl- | 4,5-dibromo-1-methyl-1H-pyrrole-2-carboxylic acid,Methyl-4,5-dibromocarboxylic acid,1-methyl-4,5-dibromopyrrole-2-carboxylic acid,4,5-dibromo-1-methylpyrrole-2-carboxylic acid | Others |
1H-Pyrrole-2-carboxylic acid, 4,5-dibromo-1-methyl- (1-methyl-4,5-dibromopyrrole-2-carboxylic acid) is a marine derived natural products found in Agelas flabelliformis. | |||
TN7166 | 2,4,6-Tribromophenol | Bromol,Xeroform,Tribromophenol | Others |
2,4,6-Tribromophenol (Bromol) is a marine derived natural products found in Phoronopsis harmeri. | |||
------------------------ More ------------------------ |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-00785 | Bacteriorhodopsin Protein, Halobacterium halobium, Recombinant (His & Myc & SUMO) | Halobacterium halobium | E. coli |
Light-driven proton pump. | |||
TMPY-03860 | Endothelin B Receptor Protein, Human, Recombinant (mFc) | Human | HEK293 Cells |
Endothelin B Receptor Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 34.4 kDa and the accession number is P24530-1. | |||
TMPY-00181 | Endothelin B Receptor Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Endothelin B Receptor Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 9.5 kDa and the accession number is P24530-1. | |||
TMPJ-00067 | BAFFR/TNFRSF13C Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C) also known as B-cell-activating factor receptor (BAFFR) and CD268 antigen, is a member of the tumor necrosis factor receptor superfamily. BAFF promotes t... | |||
TMPK-01254 | BAFFR/TNFRSF13C Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
BAFF binds to three TNF receptor superfamily members: B-cell maturation antigen (BCMA / TNFRSF17), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI/TNFRSF13B) and BAFF receptor (BAFF ... | |||
TMPK-00070 | BAFFR/TNFRSF13C Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
BAFF binds to three TNF receptor superfamily members: B-cell maturation antigen (BCMA/TNFRSF17), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI/TNFRSF13B) and BAFF receptor (BAFF R/... | |||
TMPJ-00994 | LTBR Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
It is a single-pass type I membrane protein and contains 4 TNFR-Cys repeats. The protein is a member of the tumor necrosis factor (TNF) family of receptors. It is expressed on the surface of most cell types, including ce... | |||
TMPY-01193 | Influenza A H1N1 (A/Brevig Mission/1/1918) Hemagglutinin Protein (His) | H1N1 | HEK293 Cells |
Influenza A H1N1 (A/Brevig Mission/1/1918) Hemagglutinin Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.5 kDa and the accession number is Q9WFX3. | |||
TMPY-02343 | Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA1 Protein (His) | Influenza B | HEK293 Cells |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA1 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.1 kDa and the accession number is C0LT38. | |||
TMPY-04274 | Influenza A H1N1 (A/Brevig Mission/1/1918) Nucleoprotein/NP Protein (His) | H1N1 | Baculovirus Insect Cells |
Influenza A H1N1 (A/Brevig Mission/1/1918) Nucleoprotein/NP Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 57.7 kDa and the accession number is Q5UEW0.1. | |||
TMPK-00305 | TGFBR1 Protein, Human, Recombinant (mFc & Avi) | Human | HEK293 Cells |
transforming growth factor beta receptor 1 (TGFBR1), a key stimulator of tumor proliferation and metastasis, was a direct target of miR‑98‑5p. miR‑98‑5p overexpression resulted in the downregulation of TGFBR1 and the sup... | |||
TMPY-00803 | Fibronectin Protein, Human, Recombinant (aa 607-1265, His) | Human | HEK293 Cells |
Fibronectin Protein, Human, Recombinant (aa 607-1265, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 73.2 kDa and the accession number is P02751-15. | |||
TMPY-05919 | Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His) | H1N1 | HEK293 Cells |
Influenza A H1N1 (A/Brisbane/02/2018) Hemagglutinin/HA Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 59.2 kDa. | |||
TMPY-05021 | Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Protein | Influenza B | Baculovirus Insect Cells |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Protein is expressed in Baculovirus insect cells. The predicted molecular weight is 61.7kDa and the accession number is C0LT35. | |||
TMPY-02524 | Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Protein (His) | Influenza B | HEK293 Cells |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 60 kDa and the accession number is C0LT35. | |||
TMPY-06067 | Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Protein (His) | H1N1 | Baculovirus Insect Cells |
Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 54.3 kDa. | |||
TMPJ-00335 | TGFBR2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
TGFBR2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 25-38 KDa and the accession number is Q62312-2. | |||
TMPY-01075 | Von Willebrand Factor/vWF Protein, Human, Recombinant (His) | Human | CHO Cells |
Von Willebrand Factor (VWF) is a multimeric glycoprotein involved in hemostasis in blood, binds receptors on the surface of platelets and in connective tissue, thereby mediating the adhesion of platelets to sites of vasc... | |||
TMPY-05157 | TGFBR2 Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
TGFBR2 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 17.8 kDa and the accession number is P37173. | |||
TMPY-00954 | Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA Protein (His) | H1N1 | HEK293 Cells |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 59 kDa and the accession number is B0VX44. | |||
TMPY-04848 | Influenza B (B/Brisbane/60/2008) Neuraminidase/NA Protein | Influenza B | HEK293 Cells |
Influenza B (B/Brisbane/60/2008) Neuraminidase/NA Protein is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.1 kDa and the accession number is 4CPL_A. | |||
TMPY-00957 | Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Protein (His) | H3N2 | HEK293 Cells |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 59 kDa and the accession number is A8W8K8. | |||
TMPY-05039 | LTBR Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
LTBR Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 47.8 kDa and the accession number is P36941-1. | |||
TMPY-04689 | Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E/Envelope Protein (aa 247-675, His) | DENV | Baculovirus Insect Cells |
Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E/Envelope Protein (aa 247-675, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 49.2 kDa and the accession nu... | |||
TMPY-01134 | Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin Protein (His) | H1N1 | HEK293 Cells |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.7 kDa and the accession number is B0VX44. | |||
TMPH-01519 | HIV-1 (group M, subtype C, isolate 92BR025) Protein Vpr (His & Myc) | HIV-1 | E. coli |
HIV-1 (group M, subtype C, isolate 92BR025) Protein Vpr (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 18.9 kDa and the accession number is O12160. | |||
TMPH-03424 | Rotavirus A (strain Nebraska calf diarrhea virus) VP4 Protein (His & Myc) | RV-A | E. coli |
Rotavirus A (strain Nebraska calf diarrhea virus) VP4 Protein (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 33.2 kDa and the accession number is P174... | |||
TMPK-00306 | TGFBR1 Protein, Human, Recombinant (mFc & Avi), Biotinylated | Human | HEK293 Cells |
transforming growth factor beta receptor 1 (TGFBR1), a key stimulator of tumor proliferation and metastasis, was a direct target of miR‑98‑5p. miR‑98‑5p overexpression resulted in the downregulation of TGFBR1 and the sup... | |||
TMPH-00015 | Abrin-d Protein, Abrus precatorius, Recombinant (His & Myc) | Abrus precatorius | E. coli |
The A chain is responsible for inhibiting protein synthesis through the catalytic inactivation of 60S ribosomal subunits by removing adenine from position 4,324 of 28S rRNA.; The B chain is a galactose-specific lectin th... | |||
TMPH-00018 | 29 kDa outer membrane Protein, Acinetobacter baumannii, Recombinant (His & Myc & SUMO) | Acinetobacter baumannii | E. coli |
May be involved in transporting molecules across the outer membrane. | |||
TMPY-04871 | HIV-1 (group M, subtype C, strain 92BR025) gp140 Protein (Fc) | HIV | HEK293 Cells |
HIV-1 (group M, subtype C, strain 92BR025) gp140 Protein (Fc) is expressed in HEK293 mammalian cells with Fc tag. The predicted molecular weight is 99.9 kDa and the accession number is O12164. | |||
TMPH-02657 | Fibrin Protein, Mouse, Recombinant (His & Myc) | Mouse | Baculovirus Insect Cells |
N/A. Fibrin Protein, Mouse, Recombinant (His & Myc) is expressed in Baculovirus insect cells with N-10xHis and C-Myc tag. The predicted molecular weight is 26.5 kDa and the accession number is Q9CQS3. | |||
TMPY-05810 | TGFBR2 Protein, Human, Recombinant (His & hFc), Biotinylated | Human | HEK293 Cells |
TGFBR2 Protein, Human, Recombinant (His & hFc), Biotinylated is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 43.4 kDa and the accession number is P37173. | |||
TMPH-01040 | CBR1 Protein, Human, Recombinant (His) | Human | P. pastoris (Yeast) |
CBR1 Protein, Human, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 32.2 kDa and the accession number is P16152. | |||
TMPH-01334 | Fibrinopeptide A Protein, Human, Recombinant (His) | Human | E. coli |
Fibrinopeptide A Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 25.1 kDa and the accession number is Q8WW76. | |||
TMPY-04440 | Brk Protein, Mouse, Recombinant (His & GST) | Mouse | Baculovirus Insect Cells |
Brk Protein, Mouse, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 79.8 kDa and the accession number is Q64434. | |||
TMPH-02974 | Von Willebrand Factor/vWF Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli |
Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GP... | |||
TMPH-01366 | GABRA1 Protein, Human, Recombinant (His) | Human | E. coli |
GABRA1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 29.9 kDa and the accession number is P14867. | |||
TMPY-05099 | GBA/glucocerebrosidase Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB). ASAH1 (acid ceramida... | |||
TMPH-03037 | Alpha-cobratoxin Protein, Naja kaouthia, Recombinant (GST & His & Myc) | Naja kaouthia | E. coli |
Monomer: binds with high affinity to muscular (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND) nAChR (tested on Torpedo californica, Kd=0.2-4.5 nM) and neuronal alpha-7/CHRNA7 nicotinic acetylcholine receptors (Kd=... | |||
TMPY-03632 | EFNB2A Protein, Danio rerio (zebrafish), Recombinant (hFc) | Danio rerio (zebrafish) | HEK293 Cells |
EFNB2A Protein, Danio rerio (zebrafish), Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 48.9 kDa and the accession number is O73874. | |||
TMPH-00642 | K99 fimbrial Protein, E. coli, Recombinant (His & SUMO) | E. coli | E. coli |
Fimbriae (also called pili), polar filaments radiating from the surface of the bacterium to a length of 0.5-1.5 micrometers and numbering 100-300 per cell, enable bacteria to colonize the epithelium of specific host orga... | |||
TMPY-05862 | Influenza A H1N1 (A/swine/Cambridge/1939) Hemagglutinin/HA Protein (His) | H1N1 | HEK293 Cells |
Influenza A H1N1 (A/swine/Cambridge/1939) Hemagglutinin/HA Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 58.5 kDa. | |||
TMPH-00359 | AlkB Protein, Caulobacter vibrioides, Recombinant (His & Myc) | Caulobacter vibrioides | E. coli |
AlkB Protein, Caulobacter vibrioides, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 31.2 kDa and the accession number is B8GWW6. | |||
TMPY-06186 | Influenza B (B/Brisbane/60/2008) Nucleoprotein/NP Protein (His) | Influenza B | Baculovirus Insect Cells |
Influenza B (B/Brisbane/60/2008) Nucleoprotein/NP Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 63.1 kDa. | |||
TMPY-03867 | CBR3 Protein, Human, Recombinant (His) | Human | E. coli |
CBR3, also known as hCBR3, belongs to the short-chain dehydrogenases/reductases (SDR) family. CBR3 is expressed in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate... | |||
TMPY-01079 | Influenza A H1N1 (A/Brevig Mission/1/1918) Hemagglutinin/HA Protein (His) | H1N1 | HEK293 Cells |
Influenza A H1N1 (A/Brevig Mission/1/1918) Hemagglutinin/HA Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 58.6 kDa and the accession number is Q9WFX3. | |||
TMPY-03171 | TGFBR2 Protein, Rhesus, Recombinant (hFc) | Rhesus | HEK293 Cells |
TGFBR2 Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 42.4 kDa and the accession number is H9YUL0. | |||
TMPH-03160 | Glucomannokinase Protein, Prevotella bryantii, Recombinant | Prevotella bryantii | E. coli |
The enzyme has great affinity for glucose and mannose. Glucomannokinase Protein, Prevotella bryantii, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 2.7 kDa and the accession num... | |||
TMPH-01333 | Fibrinogen beta chain Protein, Human, Recombinant (His) | Human | E. coli |
Fibrinogen beta chain Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 54.8 kDa and the accession number is P02675. | |||
------------------------ More ------------------------ |
Cat No. | Product Name | ||
---|---|---|---|
L7000 | Bioactive Lipid Compound Library | 385 compounds | |
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ... | |||
L1000 | Approved Drug Library | 2808 compounds | |
A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2620 | Anti-Neurodegenerative Disease Compound Library | 2154 compounds | |
A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS; | |||
VM1400 | Diversity Core Library Part2 | 25920 compounds | |
DO1200 | SmartTM Library | 53200 compounds | |
L7860 | Mini Electrophilic Heterocyclic Fragment Library | 369 compounds | |
369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
L5700 | Featured Fragment Library | 246 compounds | |
A unique collection of 246 fragment-like small molecules for FBDD; | |||
L1120 | AMPK-Targeted Compound Library | 80 compounds | |
80 well-chosen unique AMPK-targeted small molecules; | |||
L7810 | High Solubility Polyfunctional Group Fragment Library | 1159 compounds | |
Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules. | |||
L6020 | Selectable Natural Product Library | 16627 compounds | |
A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species; | |||
L4660 | Anti-Nervous System Disease Library | 1246 compounds | |
Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
L6001 | Mini Fungal Metabolite Natural Product Screening Library | Inquiry | |
L3200 | Autophagy Compound Library | 1248 compounds | |
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L1110 | Microtubule-Targeted Compound Library | 142 compounds | |
A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS; | |||
L1310 | Cytoskeletal Signaling Pathway Compound Library | 759 compounds | |
A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS; | |||
L1380 | Transcription Factor-Targeted Compound Library | 695 compounds | |
Well-chosen 695 compounds with unique structures targeting transcription factor; | |||
L2120 | Anti-Cancer Clinical Compound Library | 2545 compounds | |
A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2000 | Inhibitor Library | 8328 compounds | |
A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L1710 | Anti-COVID-19 Compound Library | 1133 compounds | |
A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | |||
L2160 | Anti-Cancer Active Compound Library | 3188 compounds | |
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L1800 | Anti-Infection Compound Library | 2938 compounds | |
A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
L2151 | Chemotherapy Drug Library | 48 compounds | |
48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
L2130 | Anti-Cancer Metabolism Compound Library | 1268 compounds | |
A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
L2110 | Anti-Cancer Approved Drug Library | 1779 compounds | |
A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2192 | Anti-Pancreatic Cancer Compound Library | 2238 compounds | |
A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS; | |||
L3700 | JAK-STAT Compound Library | 252 compounds | |
A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
L3500 | Histone Modification Compound Library | 469 compounds | |
A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2700 | Adrenergic Receptor-Targeted Compound Library | 193 compounds | |
A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
L6500 | Microbial Natural Product Library | 550 compounds | |
A unique collection of 550 microbial natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L6700 | Anti-Tumor Natural Product Library | 1772 compounds | |
A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L9410 | Covalent Inhibitor Library | 1920 compounds | |
A unique collection of 1920 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. | |||
L9400 | PPI Inhibitor Library | 485 compounds | |
A unique collection of 485 PPI-related compounds for drug screening; | |||
L8710 | Cuproptosis Compound Library | 400 compounds | |
TargetMol’s Cuproptosis Compound Library is a collection of 400 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
L8700 | Ferroptosis Compound Library | 779 compounds | |
A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; | |||
L9411 | Cysteine Covalent Library | 70 compounds | |
The cysteine covalent library contains 70 compounds. | |||
L9420 | Exosome Compound Library | 76 compounds | |
76 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
L8600 | Ubiquitination Compound Library | 210 compounds | |
A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening; | |||
L8800 | Drug-Fragment Library | 1119 compounds | |
1119 drug fragments,a must-have tool for FBDD; | |||
L9610 | Cyclic Peptide Library | 55 compounds | |
55 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
L2200 | Tyrosine Kinase Inhibitor Library | 1016 compounds | |
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
L2400 | Endocrinology-Hormone Compound Library | 784 compounds | |
A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L5400 | Anti-Cardiovascular Disease Compound Library | 1408 compounds | |
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6150 | Covalent Natural Product Library | 583 compounds | |
Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
L5500 | Toxic Compound Library | 262 compounds | |
A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
L4150 | Featured Novel Bioactive Compound Library | 989 compounds | |
It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis... | |||
L4900 | Cardiotoxicity Compound Library | 131 compounds | |
A unique collection of 131 cardiotoxicity inducing compounds for toxicological study; | |||
L7110 | Anti-Hypertension Compound Library | 678 compounds | |
678 hypertension-related small molecules for high-throughput and high-content screening. | |||
L7200 | Calcium Channel Compound Library | 140 compounds | |
A unique collection of 140 calcium channel blockers and agonists for high throughput and high content screening; | |||
L7300 | Potassium Channel Blocker Library | 152 compounds | |
A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening; | |||
L7900 | Osteogenesis Compound Library | 317 compounds | |
A unique collection of 317 osteogenesis related compounds for high throughput and high content screening; | |||
L7500 | Coagulation and Anticoagulation Compound Library | 144 compounds | |
A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L7820 | High Solubility Micro Fragment Library | 1081 compounds | |
The compound library of highly soluble micro-fragments consists of 1081 low-molecular-weight fragments. | |||
L9830 | Anti-Parkinson's Disease Compound Library | 857 compounds | |
A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
L2630 | Neuronal Differentiation Compound Library | 672 compounds | |
672 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease. | |||
L9210 | Pediatric Drug Library | 972 compounds | |
A unique collection of 972 pediatric drugs for high-throughput screening and high-content screening. | |||
L6820 | Tobacco Monomer Library | 747 compounds | |
A unique collection of 747 tobacco monomer compounds for high throughput screening and high content screening; | |||
L6620 | Antiparasitic Natural Product Library | 253 compounds | |
A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
L6400 | Marine Natural Product Library | 144 compounds | |
A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L2196 | Anti-Ovarian Cancer Compound Library | 1867 compounds | |
A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study; | |||
L2194 | Anti-Colorectal Cancer Compound Library | 1545 compounds | |
1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L9230 | ReFRAME Related Library | 3210 compounds | |
A unique collection of 3210 compounds for high-throughput screening and high-content screening, | |||
L2195 | Anti-Prostate Cancer Compound Library | 2070 compounds | |
2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
L6010 | Natural Product Library | 3840 compounds | |
A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L9810 | Anti-Fibrosis Compound Library | 1180 compounds | |
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
NY1000 | Natural Product Derivatives Library | 4000 compounds | |
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
L6610 | Anti-infective Natural Product Library | 1060 compounds | |
A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L1200 | Epigenetics Compound Library | 953 compounds | |
Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L9850 | Orally Active Compound Library | 2427 compounds | |
A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening. | |||
L3900 | DNA Damage & Repair Compound Library | 910 compounds | |
A unique collection of 910 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6720 | Anti-COVID-19 Traditional Chinese Medicine Compound Library | 1147 compounds | |
A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; | |||
L5610 | Golden Scaffold Library | 10000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source; | |||
L5300 | Mitochondria-Targeted Compound Library | 812 compounds | |
A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
L4000 | Bioactive Compound Library | 14439 compounds | |
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification; | |||
L7840 | High Solubility FragLite Fragment Library | 796 compounds | |
The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
L7830 | High Solubility Pharmacophore Fragment Library | 985 compounds | |
High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
L6030 | Natural Product Derivatives Library for CADD | 163000 compounds | |
Large quantity: contains 163,000 natural product derivatives and the number is continuously updating; | |||
L5600 | Mini Scaffold Library | 5000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds; | |||
L1720 | Nucleotide Compound Library | 334 compounds | |
A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
L8100 | Cell Cycle Compound Library | 677 compounds | |
A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L4520 | Anti-Bacterial Compound Library | 904 compounds | |
A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L6110 | Alkaloid Natural Product Library | 464 compounds | |
A unique collection of 464 natural alkaloids can be used for high throughput and high content screening; | |||
L9200 | Drug Repurposing Compound Library | 4630 compounds | |
A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2540 | Gut Microbial Metabolite Library | 614 compounds | |
A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS; | |||
L6220 | Traditional Mongolian Medicine Compound Library | 950 compounds | |
A collection of 950 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
L6160 | RO5 Drug-like Natural Product Library | 2703 compounds | |
A unique collection of 2703 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
L9600 | Peptide Compound Library | 791 compounds | |
791 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
L2610 | Neurotransmitter Receptor Compound Library | 1513 compounds | |
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | |||
L6120 | Flavonoid Natural Product Library | 514 compounds | |
A unique collection of 514 flavonoids can be used for high throughput and high content screening; | |||
L2600 | Neuronal Signaling Compound Library | 2540 compounds | |
A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L1100 | Protease Inhibitor Library | 343 compounds | |
A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
L8000 | Stem Cell Differentiation Compound Library | 1197 compounds | |
A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
L8720 | Pyroptosis Compound Library | 1066 compounds | |
1066 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
L4400 | Antibiotics Library | 692 compounds | |
A unique collection of 692 compounds with antibiotic activity for new antibacterial drug screening; | |||
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3158 compounds | |
3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1020 | EMA Approved Drug Library | 657 compounds | |
L2100 | Anti-Cancer Compound Library | 7234 compounds | |
A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L6230 | Miao medicine Compound Library | 534 compounds | |
A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening. | |||
L6810 | Traditional Chinese Medicine Monomer Library | 2755 compounds | |
A unique collection of 2755 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism; | |||
L6710 | Anti-Inflammatory Traditional Chinese Medicine Compound Library | 1246 compounds | |
A collection of 1246 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study; | |||
L7700 | Neural Regeneration Compound Library | 524 compounds | |
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
L6600 | Anti-Gastroenteritis Natural Product Library | 219 compounds | |
A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
L6300 | Food as Medicine Compound Library | 1290 compounds | |
A unique collection of 1290 compounds from food as medicine for high throughput and high content screening; | |||
L9840 | Anti-Alzheimer's Disease Compound Library | 986 compounds | |
A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
L9300 | Macrocyclic Compound Library | 210 compounds | |
210 macrocyclic compounds of known activity for high-throughput, high-content screening; | |||
L9100 | Phosphatase Inhibitor Library | 79 compounds | |
A collection of 79 phosphatase inhibitors with known activity; | |||
L9500 | Target-Focused Phenotypic Screening Library | 1796 compounds | |
A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | |||
L9820 | Beta-Lactam Compound Library | 97 compounds | |
A unique collection of 97 beta-lactam compounds, can be used in HTS and HCS; | |||
L2550 | Glutamine Metabolism Compound Library | 565 compounds | |
A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ... | |||
L2520 | Glycometabolism Compound Library | 702 compounds | |
702 glycometabolism-related comounds, can be used for HTS and HCT; | |||
L2510 | Lipid Metabolism Compound Library | 492 compounds | |
A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
L2800 | Serotonin Receptor-Targeted Compound Library | 268 compounds | |
A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
L2300 | Ion Channel Inhibitor Library | 931 compounds | |
A unique collection of 931 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | |||
L2900 | Oxidation-Reduction Compound Library | 1264 compounds | |
1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
L2530 | Mouse Metabolite Compound Library | 218 compounds | |
A unique collection of 218 mouse metabolites, which can be used for HTS and HCS; | |||
L3510 | Methylation Compound Library | 128 compounds | |
128 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
L3300 | Histamine & Melatonin Receptor-Targeted Compound Library | 153 compounds | |
A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L4100 | TGF-beta/Smad Compound Library | 184 compounds | |
A unique collection of 184 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
L3100 | Hematopoietic Toxicity Compound Library | 101 compounds | |
A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
L6100 | Polyphenolic Natural Product Library | 635 compounds | |
A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L5510 | Drug-induced Liver Injury (DILI) Compound Library | 1001 compounds | |
A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | |||
L4600 | Selected Plant-Sourced Compound Library | 3048 compounds | |
A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
L4500 | Anti-Fungal Compound Library | 252 compounds | |
A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
L6130 | Terpene Natural Product Library | 516 compounds | |
A unique collection of 516 natural terpenes and terpenoids can be used for high throughput and high content screening; | |||
L8200 | Anti-Aging Compound Library | 3279 compounds | |
A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L8300 | Chromatin Modification Compound Library | 250 compounds | |
A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
L9000 | Apoptosis Compound Library | 1760 compounds | |
A unique collection of 1760 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
L7850 | High Solubility 3D Diversity Fragment Library | 1079 compounds | |
The library of highly soluble 3D structural diversity fragments contains 1079 compounds. | |||
L2560 | Metabolism Compound Library | 2320 compounds | |
A unique collection of 2320 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L2570 | Human Metabolite Library | 4454 compounds | |
A unique collection of 4454 human metabolites for high-throughput, high-content screening. | |||
L9900 | Inactive Ingredient Library | 182 compounds | |
A Collection of 182 inactive ingredients from FDA-approved drugs. | |||
L9001 | Food Additive Library | 425 compounds | |
425 food additives; | |||
DF4600 | Drug-like natural compound library | 522 compounds | |
DF4500 | Diversity Core Library Part1 | 50000 compounds | |
DO2200 | Covalent inhibitors Library | 12000 compounds | |
L9700 | Endoplasmic Reticulum Stress Compound Library | 193 compounds | |
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
L7600 | Chemokine Inhibitor Library | 59 compounds | |
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
L1580 | GPCR Compound Library Plus | 338 compounds | |
Well-chosen 338 GPCR targeting compounds with unique structures; | |||
L2180 | Anti-Cancer Compound Library Plus | 1468 compounds | |
Well-chosen 1468 anti-tumor compounds with unique structures; | |||
L1500 | GPCR Compound Library | 1940 compounds | |
A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
L4700 | Immunology/Inflammation Compound Library | 4720 compounds | |
A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
L1700 | Anti-Viral Compound Library | 1040 compounds | |
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
L3980 | DNA Damage and Repair Compound Library Plus | 667 compounds | |
Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
L1300 | PI3K-AKT-mTOR Compound Library | 420 compounds | |
A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
L1400 | MAPK Inhibitor Library | 365 compounds | |
A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases; | |||
L1510 | Nuclear Receptor Compound Library | 531 compounds | |
A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
L2150 | Anti-Cancer Drug Library | 3080 compounds | |
A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L4020 | NO PAINS Compound Library | 9384 compounds | |
TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9384 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other resea... | |||
L1610 | FDA-Approved Kinase Inhibitor Library | 263 compounds | |
A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening. | |||
L2140 | Cancer Cell Differentiation Compound Library | 406 compounds | |
A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
L1900 | Anti-Diabetic Compound Library | 683 compounds | |
A unique collection of 683 diabetes related compounds; | |||
L2152 | Targeted Therapy Drug Library | 119 compounds | |
119 tumor-targeted drugs that can be used for high-throughput and high-content screening. | |||
L2191 | Anti-Breast Cancer Compound Library | 1939 compounds | |
A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | |||
L5800 | Drug Metabolite/Impurity Library | 197 compounds | |
A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
L5900 | CNS-Penetrant Compound Library | 509 compounds | |
A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L5100 | Fluorochemical Library | 574 compounds | |
A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
L4800 | Angiogenesis related Compound Library | 1353 compounds | |
A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
L4510 | Anti-Parasitic Compound Library | 419 compounds | |
419 well-chosen unique anti-parasitic small molecules; | |||
L5200 | Anti-Metabolism Disease Compound Library | 1544 compounds | |
A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6750 | PBCRBS Traditional Chinese Medicine Compound Library | 580 compounds | |
A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis. | |||
L6800 | Chinese Pharmacopoeia Natural Product Library | 2051 compounds | |
A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
L6140 | Saccharide and Glycoside Natural Product Library | 362 compounds | |
A unique collection of 362 saccharides and glycosides compounds can be used for HTS and HCS; | |||
L8500 | HIF-1 Signaling Pathway Compound Library | 1336 compounds | |
A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies; | |||
L8400 | Hematonosis Compound Library | 514 compounds | |
A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
L7100 | Anti-Obesity Compound Library | 2247 compounds | |
A unique collection of 2247 anti-obesity compounds for high throughput and high content screening; | |||
L7400 | Sodium Channel Blocker Library | 118 compounds | |
A unique collection of 118 sodium channel blockers and agonists for high throughput and high content screening; | |||
L8110 | Reprogramming Compound Library | 1813 compounds | |
A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L7800 | High Solubility Fragment Library | 2728 compounds | |
Structurally diverse, medicinally active, and unique chemistry (strong IP potential); | |||
L2910 | Antioxidant Compound Library | 1314 compounds | |
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ... | |||
L3410 | Preclinical Compound Library | 701 compounds | |
A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2501 | Human Endogenous Metabolite Compound Library Plus | 1283 compounds | |
A unique collection of 1283 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening. | |||
L2500 | Human Endogenous Metabolite Library | 499 compounds | |
A collection of 499 selected human endogenous metabolites for high throughput and high content screening. | |||
L3800 | NF-κB Signaling Compound Library | 729 compounds | |
A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
L4300 | Wnt/Hedgehog/Notch Compound Library | 237 compounds | |
A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
L3600 | Cytokine Inhibitor Library | 604 compounds | |
A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
L9860 | Antidepressant Compound Library | 1163 compounds | |
1163 compounds associated with depression that can be used for high-throughput and high-content screening | |||
L6740 | Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library | 382 compounds | |
A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
L6200 | The Yao nationality medicine Library | 221 compounds | |
A collection of 221 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
L6730 | Anti-virus Traditional Chinese Medicine Monomer Library | 268 compounds | |
A collection of 268 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. | |||
L2193 | Anti-Liver Cancer Compound Library | 1787 compounds | |
1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | |||
L2521 | Glycolysis Compound Library | 555 compounds | |
555 glycolysis-related active compounds for high-throughput and high-content screening. | |||
L7870 | Carboxylic Acid Fragment Library With Solubility | 1806 compounds | |
L2010 | Highly Selective Inhibitor Library | 575 compounds | |
A collection of 575 highly selective inhibitors | |||
L6900 | Rare Natural Product Library | 693 compounds | |
A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
L6000 | Natural Product Library for HTS | 4533 compounds | |
A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can... | |||
L6210 | Tibetan medicine Compound Library | 747 compounds | |
A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 compounds | |
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
L2190 | Anti-Lung Cancer Compound Library | 1702 compounds | |
A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | |||
L1520 | Membrane Protein-targeted Compound Library | 4175 compounds | |
L3400 | Clinical Compound Library | 3404 compounds | |
A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
L2170 | Immuno-Oncology Compound Library | 449 compounds | |
A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L4200 | FDA-Approved Drug Library | 1729 compounds | |
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1600 | Kinase Inhibitor Library | 2720 compounds | |
A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
L4010 | Bioactive Compounds Library Max | 22555 compounds | |
A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. |